: Cardiac resynchronization therapy (CRT) is one of the most effective therapies for heart failure with reduced ejection fraction and leads to improved quality of life, reductions in heartfailure hospitalization rates and reduces all-cause mortality. Nevertheless, up to two-thirds ofeligible patients are not referred for CRT. Furthermore, post implantation follow-up is oftenfragmented and suboptimal, hampering the potential maximal treatment effect. This jointposition statement from three ESC Associations, HFA, EHRA and EACVI focuses onoptimized implementation of CRT. We offer theoretical and practical strategies to achievemore comprehensive CRT referral and post-procedural care by focusing on four actionabledomains; (I) overcoming CRT under-utilization, (II) better understanding of pre-implantcharacteristics, (III) abandoning the term 'non-response' and replacing this by the concept ofdisease modification, and (IV) implementing a dedicated post-implant CRT care pathway.

Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care: A joint position statement from the Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), and European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology / Mullens, Wilfried; Auricchio, Angelo; Martens, Pieter; Witte, Klaus; Cowie, Martin R; Delgado, Victoria; Dickstein, Kenneth; Linde, Cecilia; Vernooy, Kevin; Leyva, Francisco; Bauersachs, Johann; Israel, Carsten W; Lund, Lars H; Donal, Erwan; Boriani, Giuseppe; Jaarsma, Tiny; Berruezo, Antonio; Traykov, Vassil; Yousef, Zaheer; Kalarus, Zbigniew; Nielsen, Jens Cosedis; Steffel, Jan; Vardas, Panos; Coats, Andrew; Seferovic, Petar; Edvardsen, Thor; Heidbuchel, Hein; Ruschitzka, Frank; Leclercq, Christophe. - In: EUROPACE. - ISSN 1099-5129. - 23:8(2021), pp. 1324-1342. [10.1093/europace/euaa411]

Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care: A joint position statement from the Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), and European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology

Boriani, Giuseppe;
2021

Abstract

: Cardiac resynchronization therapy (CRT) is one of the most effective therapies for heart failure with reduced ejection fraction and leads to improved quality of life, reductions in heartfailure hospitalization rates and reduces all-cause mortality. Nevertheless, up to two-thirds ofeligible patients are not referred for CRT. Furthermore, post implantation follow-up is oftenfragmented and suboptimal, hampering the potential maximal treatment effect. This jointposition statement from three ESC Associations, HFA, EHRA and EACVI focuses onoptimized implementation of CRT. We offer theoretical and practical strategies to achievemore comprehensive CRT referral and post-procedural care by focusing on four actionabledomains; (I) overcoming CRT under-utilization, (II) better understanding of pre-implantcharacteristics, (III) abandoning the term 'non-response' and replacing this by the concept ofdisease modification, and (IV) implementing a dedicated post-implant CRT care pathway.
2021
23
8
1324
1342
Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care: A joint position statement from the Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), and European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology / Mullens, Wilfried; Auricchio, Angelo; Martens, Pieter; Witte, Klaus; Cowie, Martin R; Delgado, Victoria; Dickstein, Kenneth; Linde, Cecilia; Vernooy, Kevin; Leyva, Francisco; Bauersachs, Johann; Israel, Carsten W; Lund, Lars H; Donal, Erwan; Boriani, Giuseppe; Jaarsma, Tiny; Berruezo, Antonio; Traykov, Vassil; Yousef, Zaheer; Kalarus, Zbigniew; Nielsen, Jens Cosedis; Steffel, Jan; Vardas, Panos; Coats, Andrew; Seferovic, Petar; Edvardsen, Thor; Heidbuchel, Hein; Ruschitzka, Frank; Leclercq, Christophe. - In: EUROPACE. - ISSN 1099-5129. - 23:8(2021), pp. 1324-1342. [10.1093/europace/euaa411]
Mullens, Wilfried; Auricchio, Angelo; Martens, Pieter; Witte, Klaus; Cowie, Martin R; Delgado, Victoria; Dickstein, Kenneth; Linde, Cecilia; Vernooy, Kevin; Leyva, Francisco; Bauersachs, Johann; Israel, Carsten W; Lund, Lars H; Donal, Erwan; Boriani, Giuseppe; Jaarsma, Tiny; Berruezo, Antonio; Traykov, Vassil; Yousef, Zaheer; Kalarus, Zbigniew; Nielsen, Jens Cosedis; Steffel, Jan; Vardas, Panos; Coats, Andrew; Seferovic, Petar; Edvardsen, Thor; Heidbuchel, Hein; Ruschitzka, Frank; Leclercq, Christophe
File in questo prodotto:
File Dimensione Formato  
euaa411.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 844.61 kB
Formato Adobe PDF
844.61 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1251513
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 15
social impact